✦ LIBER ✦

Rocaglamide sensitizes leukemic T cells to activation-induced cell death by differential regulation of CD95L and c-FLIP expression

✍ Scribed by Zhu, J Y; Giaisi, M; Köhler, R; Müller, W W; Mühleisen, A; Proksch, P; Krammer, P H; Li-Weber, M

Book ID: 109841293
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 479 KB
Volume: 16
Category: Article
ISSN: 1350-9047
DOI: 10.1038/cdd.2009.42

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regulation of cell surface expression of

Regulation of cell surface expression of Fas (CD95) ligand and susceptibility to Fas (CD95)-mediated apoptosis in activation-induced T cell death involves calcineurin and protein kinase C, respectively

✍ Réka Tóth; Éva Szegezdi; Gábor Molnár; Janet M. Lord; László Fésüs; Zsuzsa Szond 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 2 views

Induction of sensitivity to activation-i

Induction of sensitivity to activation-induced death in primary CD4+ cells: A role for interleukin-2 in the negative regulation of responses by mature CD4+ T cells

✍ Ruduan Wang; Amy M. Rogers; Brian J. Rush; John H. Russell 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 917 KB

Activation-induced apoptosis and cell su

Activation-induced apoptosis and cell surface expression of Fas (CD95) ligand are reciprocally regulated by retinoic acid receptor α and γ and involve nur77 in T cells

✍ Réka Tóth; Éva Szegezdi; Uwe Reichert; Jean-Michel Bernardon; Serge Michel; Phil 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views

Treatment of the P815 murine mastocytoma

Treatment of the P815 murine mastocytoma with cisplatin or etoposide up-regulates cell-surface Fas (CD95) expression and increases sensitivity to anti-Fas antibody-mediated cytotoxicity and to lysis by anti-CD3-activated killer-T cells

✍ Brent A. Williams; Andrew P. Makrigiannis; Jonathan Blay; David W. Hoskin 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 122 KB 👁 2 views

We have investigated the effect of pre-treatment with the anti-cancer drugs cisplatin and etoposide on the susceptibility of P815 murine mastocytoma cells to lysis by murine spleen-derived anti-CD3-activated killer-T (AK-T) cells. A 20 hr pre-treatment with cisplatin (0.2-2 microg/ml) or etoposide (